Reconstructing the evolutionary history of multiple myeloma
Multiple myeloma is the second most common lymphoproliferative disorders, characterized by aberrant expansion of monoclonal plasma cells. In the last …
Related Articles
ScienceDirect
ScienceDirect is the world’s leading source for scientific, technical, and medical research. Explore journals, books and articles.
FDA Approves Linvoseltamab-Gcpt for Treatment of Relapsed or Refractory Multiple Myeloma
The treatment becomes the first approved BCMAxCD3 bispecific antibody with the potential to achieve biweekly or monthly dosing in patients with relapsed/refractory multiple myeloma.
Potential New Standard of Care Emerges in Multiple Myeloma
The randomized, multicenter ADVANCE trial tested the effectiveness of adding daratumumab to the standard three-part therapy regimen of carfilzomib, lenalidomide, and dexamethasone in patients with…
Potential New Standard of Care Emerges in Multiple Myeloma
The randomized, multicenter ADVANCE trial tested the effectiveness of adding daratumumab to the standard three-part therapy regimen of carfilzomib, lenalidomide, and dexamethasone in patients with…
Paper: The Early Benefits and Psychological Effects of Screening for Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study
Program: Oral and Poster Abstracts Type: Oral Session: 654. MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Screening to Vaccines–The Spectrum of…
Management of Heart Failure With Reduced Ejection Fraction
Heart failure with reduced ejection fraction (HFrEF) is a complex and progressive clinical condition characterized by dyspnea and functional impairmen…
Management of Heart Failure With Reduced Ejection Fraction
Heart failure with reduced ejection fraction (HFrEF) is a complex and progressive clinical condition characterized by dyspnea and functional impairmen…
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force
Implementation of Treat-to-Target (T2T) in routine clinical practice remains low in systemic lupus erythematosus (SLE). Real-world data reveal excessi…
Reconsidering “inclusive language:” Consequences for healthcare and equitableness of a growing linguistic movement to address gender identity with a path forward
Increasingly, the language of female reproduction is changing, so terms directly referencing people’s sex are replaced with terms obscuring sex, a lan…
Functional diversification of dietary plant small molecules by the gut microbiome
Plants are composed of diverse secondary metabolites (PSMs), which are widely associated with human health. Whether and how the gut microbiome mediate…
